Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient populationPSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in ...
Information and communication technologies (ICTs) driven by artificial intelligence (AI) are generating data at an unprecedented rate. Every internet search, AI-generated image, recommendation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results